COO
Cooper Cos Inc/The
NASDAQ · Health Care
$82.10
+2.00 (+2.50%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 4.01B | 3.74B | 3.28B | 3.04B | 3.62B |
| Net Income | 367.36M | 307.99M | 640.87M | 462.64M | 523.71M |
| EPS | — | — | — | — | — |
| Profit Margin | 9.2% | 8.7% | 19.5% | 15.2% | 14.5% |
| Rev Growth | +7.4% | +7.4% | +2.5% | +17.9% | +23.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 1.88B | 1.88B | 2.40B | 2.83B | 2.88B |
| Total Equity | 6.17B | 6.17B | 10.36B | 11.16B | 10.53B |
| D/E Ratio | 0.30 | 0.30 | 0.23 | 0.25 | 0.27 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 856.13M | 757.64M | 748.21M | 674.55M | 906.37M |
| Free Cash Flow | — | — | 398.13M | 297.18M | 404.54M |